Cargando…

Novel Nasal in situ Gelling System for Treatment of Sinusitis

In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, M. R., Surve, S. A., Menon, M. D.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846489/
_version_ 1782179483491500032
author Mehta, M. R.
Surve, S. A.
Menon, M. D.
author_facet Mehta, M. R.
Surve, S. A.
Menon, M. D.
author_sort Mehta, M. R.
collection PubMed
description In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in vitro drug release, mucoadhesive strength, preservative efficacy and stability. In vitro release studies revealed significant prolonged released of both drugs up to 24 h as against only 2 h with drug solution. Formulations were found to stable over period of 3 months. In vivo nasal residence time of in situ gel by gamma scintigraphy was found to be significantly higher (6 h) in comparison to drug solution (15 min). It can be concluded that Poloxamers in combination with HPMC are suitable to develop stable, safe in situ temperature-based mucoadhesive gelling systems with prolonged nasal residence time.
format Text
id pubmed-2846489
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28464892010-04-06 Novel Nasal in situ Gelling System for Treatment of Sinusitis Mehta, M. R. Surve, S. A. Menon, M. D. Indian J Pharm Sci Abstract In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in vitro drug release, mucoadhesive strength, preservative efficacy and stability. In vitro release studies revealed significant prolonged released of both drugs up to 24 h as against only 2 h with drug solution. Formulations were found to stable over period of 3 months. In vivo nasal residence time of in situ gel by gamma scintigraphy was found to be significantly higher (6 h) in comparison to drug solution (15 min). It can be concluded that Poloxamers in combination with HPMC are suitable to develop stable, safe in situ temperature-based mucoadhesive gelling systems with prolonged nasal residence time. Medknow Publications 2009 /pmc/articles/PMC2846489/ Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Mehta, M. R.
Surve, S. A.
Menon, M. D.
Novel Nasal in situ Gelling System for Treatment of Sinusitis
title Novel Nasal in situ Gelling System for Treatment of Sinusitis
title_full Novel Nasal in situ Gelling System for Treatment of Sinusitis
title_fullStr Novel Nasal in situ Gelling System for Treatment of Sinusitis
title_full_unstemmed Novel Nasal in situ Gelling System for Treatment of Sinusitis
title_short Novel Nasal in situ Gelling System for Treatment of Sinusitis
title_sort novel nasal in situ gelling system for treatment of sinusitis
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846489/
work_keys_str_mv AT mehtamr novelnasalinsitugellingsystemfortreatmentofsinusitis
AT survesa novelnasalinsitugellingsystemfortreatmentofsinusitis
AT menonmd novelnasalinsitugellingsystemfortreatmentofsinusitis